Abstract
Eosinophilia is typically secondary, that is, reactive, in nature and is associated with a wide variety of neoplastic and non-neoplastic disorders. Clonal eosinophilia is also seen in a wide variety of hematopoietic neoplasms, and sub-classification can be diagnostically challenging. A proper evaluation of persistent eosinophilia involves correlation of clinical history, laboratory data, cellular morphology, and ancillary testing. Knowledge of appropriate ancillary testing is necessary for a timely diagnosis. We present a review of the literature regarding eosinophilia, including the 2016 World Health Organization (WHO) update of WHO-defined eosinophilic disorders. We also present a review of eosinophilia in a case-based format including guidelines for evaluation of both routine and challenging cases. The purpose of this guideline is not to provide an in-depth discussion of each diagnosis, but rather a practical method that all pathologists can utilize to investigate eosinophilia.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 153-161 |
| Number of pages | 9 |
| Journal | International Journal of Laboratory Hematology |
| Volume | 41 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 2019 |
Keywords
- blood
- bone marrow
- eosinophils
- leukemia
- morphology
- myeloid
ASJC Scopus subject areas
- Hematology
- Clinical Biochemistry
- Biochemistry, medical
Fingerprint
Dive into the research topics of 'How I investigate Eosinophilia'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS